{"id":86104,"date":"2021-04-21T10:12:41","date_gmt":"2021-04-21T13:12:41","guid":{"rendered":"https:\/\/iclos.global\/eng\/?post_type=product&#038;p=86104"},"modified":"2021-04-22T13:08:42","modified_gmt":"2021-04-22T16:08:42","slug":"winrho-sdf","status":"publish","type":"product","link":"https:\/\/iclos.global\/eng\/producto\/winrho-sdf\/","title":{"rendered":"Winrho SDF"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row row_height_percent=\u00bb0&#8243; overlay_alpha=\u00bb50&#8243; gutter_size=\u00bb3&#8243; column_width_percent=\u00bb100&#8243; shift_y=\u00bb0&#8243; z_index=\u00bb0&#8243; el_class=\u00bbborro-en-producto\u00bb][vc_column width=\u00bb1\/1&#8243;][vc_column_text]<\/p>\n<h3>Principio activo: Inmunoglobulina IgG con reconocimiento del ant\u00edgeno Rho.<br \/>\nPresentaciones: 120 mcg, 0.5ml, 600 UI, vial<br \/>\n300mcg, 1.3ml, 1500 UI, vial<\/h3>\n<p>&nbsp;<\/p>\n<h4><\/h4>\n<p><strong>Mecanismo de acci\u00f3n y blancos moleculares (biol\u00f3gicos)<\/strong><\/p>\n<p>La inmunoglobulina anti Rho es una inmunoglobulina de plasma humano que evita que personas Rh (-) presenten una respuesta inmune frente a eritrocitos Rh (+).[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=\u00bb0&#8243; overlay_alpha=\u00bb50&#8243; gutter_size=\u00bb3&#8243; column_width_percent=\u00bb100&#8243; shift_y=\u00bb0&#8243; z_index=\u00bb0&#8243; el_class=\u00bbcatalogo-item\u00bb][vc_column width=\u00bb1\/1&#8243;][vc_row_inner][vc_column_inner width=\u00bb1\/1&#8243;][vc_empty_space empty_h=\u00bb0&#8243;][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=\u00bb5\/6&#8243;][vc_column_text][\/vc_column_text][\/vc_column_inner][vc_column_inner width=\u00bb1\/6&#8243;][vc_column_text]<img decoding=\"async\" class=\"alignnone wp-image-85422 size-full\" src=\"https:\/\/iclos.global\/eng\/wp-content\/uploads\/2020\/05\/logo-prod.png\" alt=\"\" width=\"128\" height=\"46\" \/>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<h3>Principio activo: Inmunoglobulina IgG con reconocimiento del ant\u00edgeno Rho.<br \/>\nPresentaciones: 120 mcg, 0.5ml, 600 UI, vial<br \/>\n300mcg, 1.3ml, 1500 UI, vial<\/h3>\n<p>&nbsp;<\/p>\n<h4><\/h4>\n<p><strong>Mecanismo de acci\u00f3n y blancos moleculares (biol\u00f3gicos)<\/strong><\/p>\n<p>La inmunoglobulina anti Rho es una inmunoglobulina de plasma humano que evita que personas Rh (-) presenten una respuesta inmune frente a eritrocitos Rh (+).<\/p>\n<p><strong>Indicaciones terap\u00e9uticas<\/strong><\/p>\n<ul>\n<li>Adultos con p\u00farpura inmune trombocitop\u00e9nica cr\u00f3nica o aguda<\/li>\n<li>Tratamiento de supresi\u00f3n de la isoinmunizaci\u00f3n de Rhesus (Rh)<\/li>\n<li>Mujeres con embarazos y otras condiciones obstetricias que son Rho(D)-negativas, con un embarazo incompatible Rh<\/li>\n<li>Transfusiones incompatibles en individuos RH(D)-negativos que les transfundieron sangre con Rho(D)-positiva.<\/li>\n<\/ul>\n<p><strong>Aprobaciones y pautas (FDA; EMA; ASCO; ESMO)<\/strong><\/p>\n<p>EMA y FDA aprueban el uso de Inmunoglobulinas anti Rho para las indicaciones anteriormente mencionadas.<\/p>\n<p><strong>Dosis y plan terap\u00e9utico<\/strong><\/p>\n<p>El plan terap\u00e9utico var\u00eda seg\u00fan indicaci\u00f3n. Las dosis administradas var\u00edan en el rango comprendido entre 250 \u2013 1500 UI por v\u00eda intravenosa, en dosis \u00fanicas.<\/p>\n<p><em>Por m\u00e1s informaci\u00f3n ver la ficha t\u00e9cnica del producto.<\/em><\/p>\n","protected":false},"featured_media":86132,"template":"","meta":[],"product_cat":[125],"product_tag":[],"class_list":{"0":"post-86104","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-sin-categorizar","7":"pa_area-terapeutica-hemoderivados","8":"pa_nombre-winrho-sdf","9":"pa_principio-activo-inmunoglobulina-igg-con-reconocimiento-del-antigeno-rho","11":"first","12":"instock","13":"shipping-taxable","14":"product-type-simple"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Winrho SDF - ICLOS<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/iclos.global\/eng\/producto\/winrho-sdf\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Winrho SDF - ICLOS\" \/>\n<meta property=\"og:description\" content=\"Principio activo: Inmunoglobulina IgG con reconocimiento del ant\u00edgeno Rho. Presentaciones: 120 mcg, 0.5ml, 600 UI, vial 300mcg, 1.3ml, 1500 UI, vial &nbsp;  Mecanismo de acci\u00f3n y blancos moleculares (biol\u00f3gicos)  La inmunoglobulina anti Rho es una inmunoglobulina de plasma humano que evita que personas Rh (-) presenten una respuesta inmune frente a eritrocitos Rh (+).  Indicaciones terap\u00e9uticas   Adultos con p\u00farpura inmune trombocitop\u00e9nica cr\u00f3nica o aguda  Tratamiento de supresi\u00f3n de la isoinmunizaci\u00f3n de Rhesus (Rh)  Mujeres con embarazos y otras condiciones obstetricias que son Rho(D)-negativas, con un embarazo incompatible Rh  Transfusiones incompatibles en individuos RH(D)-negativos que les transfundieron sangre con Rho(D)-positiva.  Aprobaciones y pautas (FDA; EMA; ASCO; ESMO)  EMA y FDA aprueban el uso de Inmunoglobulinas anti Rho para las indicaciones anteriormente mencionadas.  Dosis y plan terap\u00e9utico  El plan terap\u00e9utico var\u00eda seg\u00fan indicaci\u00f3n. Las dosis administradas var\u00edan en el rango comprendido entre 250 \u2013 1500 UI por v\u00eda intravenosa, en dosis \u00fanicas.  Por m\u00e1s informaci\u00f3n ver la ficha t\u00e9cnica del producto.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/iclos.global\/eng\/producto\/winrho-sdf\/\" \/>\n<meta property=\"og:site_name\" content=\"ICLOS\" \/>\n<meta property=\"article:modified_time\" content=\"2021-04-22T16:08:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/iclos.global\/eng\/wp-content\/uploads\/2021\/04\/nada200.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"200\" \/>\n\t<meta property=\"og:image:height\" content=\"200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/iclos.global\/eng\/producto\/winrho-sdf\/\",\"url\":\"https:\/\/iclos.global\/eng\/producto\/winrho-sdf\/\",\"name\":\"Winrho SDF - ICLOS\",\"isPartOf\":{\"@id\":\"https:\/\/iclos.global\/eng\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/iclos.global\/eng\/producto\/winrho-sdf\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/iclos.global\/eng\/producto\/winrho-sdf\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/iclos.global\/eng\/wp-content\/uploads\/2021\/04\/nada200.jpg\",\"datePublished\":\"2021-04-21T13:12:41+00:00\",\"dateModified\":\"2021-04-22T16:08:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/iclos.global\/eng\/producto\/winrho-sdf\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/iclos.global\/eng\/producto\/winrho-sdf\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/iclos.global\/eng\/producto\/winrho-sdf\/#primaryimage\",\"url\":\"https:\/\/iclos.global\/eng\/wp-content\/uploads\/2021\/04\/nada200.jpg\",\"contentUrl\":\"https:\/\/iclos.global\/eng\/wp-content\/uploads\/2021\/04\/nada200.jpg\",\"width\":200,\"height\":200},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/iclos.global\/eng\/producto\/winrho-sdf\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/iclos.global\/eng\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tienda\",\"item\":\"https:\/\/iclos.global\/eng\/tienda\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Winrho SDF\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/iclos.global\/eng\/#website\",\"url\":\"https:\/\/iclos.global\/eng\/\",\"name\":\"MEGALABS\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/iclos.global\/eng\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Winrho SDF - ICLOS","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/iclos.global\/eng\/producto\/winrho-sdf\/","og_locale":"es_ES","og_type":"article","og_title":"Winrho SDF - ICLOS","og_description":"Principio activo: Inmunoglobulina IgG con reconocimiento del ant\u00edgeno Rho. Presentaciones: 120 mcg, 0.5ml, 600 UI, vial 300mcg, 1.3ml, 1500 UI, vial &nbsp;  Mecanismo de acci\u00f3n y blancos moleculares (biol\u00f3gicos)  La inmunoglobulina anti Rho es una inmunoglobulina de plasma humano que evita que personas Rh (-) presenten una respuesta inmune frente a eritrocitos Rh (+).  Indicaciones terap\u00e9uticas   Adultos con p\u00farpura inmune trombocitop\u00e9nica cr\u00f3nica o aguda  Tratamiento de supresi\u00f3n de la isoinmunizaci\u00f3n de Rhesus (Rh)  Mujeres con embarazos y otras condiciones obstetricias que son Rho(D)-negativas, con un embarazo incompatible Rh  Transfusiones incompatibles en individuos RH(D)-negativos que les transfundieron sangre con Rho(D)-positiva.  Aprobaciones y pautas (FDA; EMA; ASCO; ESMO)  EMA y FDA aprueban el uso de Inmunoglobulinas anti Rho para las indicaciones anteriormente mencionadas.  Dosis y plan terap\u00e9utico  El plan terap\u00e9utico var\u00eda seg\u00fan indicaci\u00f3n. Las dosis administradas var\u00edan en el rango comprendido entre 250 \u2013 1500 UI por v\u00eda intravenosa, en dosis \u00fanicas.  Por m\u00e1s informaci\u00f3n ver la ficha t\u00e9cnica del producto.","og_url":"https:\/\/iclos.global\/eng\/producto\/winrho-sdf\/","og_site_name":"ICLOS","article_modified_time":"2021-04-22T16:08:42+00:00","og_image":[{"width":200,"height":200,"url":"https:\/\/iclos.global\/eng\/wp-content\/uploads\/2021\/04\/nada200.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/iclos.global\/eng\/producto\/winrho-sdf\/","url":"https:\/\/iclos.global\/eng\/producto\/winrho-sdf\/","name":"Winrho SDF - ICLOS","isPartOf":{"@id":"https:\/\/iclos.global\/eng\/#website"},"primaryImageOfPage":{"@id":"https:\/\/iclos.global\/eng\/producto\/winrho-sdf\/#primaryimage"},"image":{"@id":"https:\/\/iclos.global\/eng\/producto\/winrho-sdf\/#primaryimage"},"thumbnailUrl":"https:\/\/iclos.global\/eng\/wp-content\/uploads\/2021\/04\/nada200.jpg","datePublished":"2021-04-21T13:12:41+00:00","dateModified":"2021-04-22T16:08:42+00:00","breadcrumb":{"@id":"https:\/\/iclos.global\/eng\/producto\/winrho-sdf\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/iclos.global\/eng\/producto\/winrho-sdf\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/iclos.global\/eng\/producto\/winrho-sdf\/#primaryimage","url":"https:\/\/iclos.global\/eng\/wp-content\/uploads\/2021\/04\/nada200.jpg","contentUrl":"https:\/\/iclos.global\/eng\/wp-content\/uploads\/2021\/04\/nada200.jpg","width":200,"height":200},{"@type":"BreadcrumbList","@id":"https:\/\/iclos.global\/eng\/producto\/winrho-sdf\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/iclos.global\/eng\/"},{"@type":"ListItem","position":2,"name":"Tienda","item":"https:\/\/iclos.global\/eng\/tienda\/"},{"@type":"ListItem","position":3,"name":"Winrho SDF"}]},{"@type":"WebSite","@id":"https:\/\/iclos.global\/eng\/#website","url":"https:\/\/iclos.global\/eng\/","name":"MEGALABS","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/iclos.global\/eng\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"}]}},"_links":{"self":[{"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/product\/86104","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/types\/product"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/media\/86132"}],"wp:attachment":[{"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/media?parent=86104"}],"wp:term":[{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/product_cat?post=86104"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/product_tag?post=86104"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}